MedTrace Logo

Study of High Risk Non Invasive Prenatal Test Population

NCT04737070 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2021-02-03

No results posted yet for this study

Summary

The investigator want to study the population of high risk (over 1/50) of Trisomy 21.

According to french guidelines, these patients needs to have a invasive test (such as amniocentesis) but some patients prefer to have a Non Invasive Prenatal Test, with a potential lack of information.

Conditions

  • Trisomy 21

Interventions

BIOLOGICAL

Prenatal test for Trisomy 21 screening

prenatal routine test for Trisomy 21 screening (blood test + nuchal translucency test)

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2021-04-01
Completion
2021-07-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04737070 on ClinicalTrials.gov